Today: 20 May 2026
Dow Jones stock Boeing edges up after Alaska lands 110-plane deal
7 January 2026
1 min read

Dow Jones stock Boeing edges up after Alaska lands 110-plane deal

NEW YORK, January 7, 2026, 10:06 EST — Regular session

  • Boeing shares rose after Alaska Airlines placed its biggest-ever aircraft order, led by 737 MAX 10 jets.
  • The deal puts fresh focus on Boeing’s ability to certify the MAX 10 and raise output.
  • Investors now look to Boeing’s late-January results for updates on deliveries and cash flow.

Boeing shares were up 0.3% at $230.54 in morning trade on Wednesday after Alaska Airlines said it would order 105 737 MAX 10 jets and five 787 widebodies, its largest fleet order. Alaska Air Group shares were down 1.4%.

For Boeing, it is a clean headline: a big U.S. airline is committing to its newest narrowbody variant at a moment when the manufacturer is still trying to show steadier execution. The order also stretches far into the next decade, which means the real market test is whether Boeing can deliver on schedule.

Alaska’s CEO Ben Minicucci called the purchase part of a long-term expansion plan, saying, “These planes will fuel our expansion to more destinations across the globe.” Boeing Commercial Airplanes chief Stephanie Pope said the company was “honored” Alaska had “placed their trust” in Boeing’s 737 and 787 programs. Boeing Investors

Alaska said the order extends its delivery stream through 2035 and includes rights for 35 additional 737-10 aircraft. The airline said it aims to grow its fleet to more than 475 aircraft by 2030 and more than 550 by 2035, and it flagged Seattle as a long-haul gateway as it pushes further into Europe and Asia.

The MAX 10 — the biggest version of the 737 family — remains central to Boeing’s pitch on unit costs and capacity, but the jet still needs certification, a timeline investors watch closely. Boeing also needs production momentum after the FAA last year cleared it to lift 737 MAX output to 42 planes a month, a step meant to help stabilize deliveries and cash generation.

There is a catch. Certification setbacks, supplier snags or renewed regulatory pressure could push deliveries to the right, dulling the near-term benefit of a large order and reviving worries about Boeing’s ability to convert backlog into cash.

Traders will also keep an eye on Boeing’s next results for hard numbers on deliveries, cash flow and any updates on program milestones. Nasdaq’s earnings calendar currently points to an expected report date of January 27, though companies can still confirm dates closer to release.

Beyond company specifics, the next U.S. catalyst is Friday’s government jobs report, which can sway rate expectations and, by extension, industrial shares. The Bureau of Labor Statistics has scheduled the December employment report for January 9 at 8:30 a.m. ET.

Stock Market Today

  • Tesla Q1 2026 Earnings Beat; Stock Faces Mixed Outlook for 2030
    May 20, 2026, 10:24 AM EDT. Tesla (TSLA) reported Q1 2026 earnings per share (EPS) of $0.41, exceeding the $0.36 consensus, with automotive gross margin rising to 21.1% from 16.2%. Operating income increased 135.8% year-on-year (YoY), and services plus Full Self-Driving (FSD) revenue jumped 42% to $3.75 billion, with 1.28 million active FSD subscriptions up 51%. Despite strong fundamentals, Tesla shares fell 8.83% year-to-date to $409.99 amid skepticism about AI monetization and scaling autonomy. Wall Street's average target is about $412, while a proprietary model estimates a base case price of $510 by 2030, with a bull case of $645. Achieving $650 requires significant price-to-earnings multiple expansion or sharp EPS growth from AI ventures, amid challenges like increased operating expenses and production constraints.

Latest articles

POET Technologies Jumps After $400M AI Photonics Raise, Dilution Questions Linger

POET Technologies Jumps After $400M AI Photonics Raise, Dilution Questions Linger

20 May 2026
POET Technologies shares rose 11% to $14.55 in early Nasdaq trading Wednesday after closing a US$400 million direct offering of 19 million shares and warrants. The rebound followed an 8% drop Tuesday on dilution concerns. The company reported Q1 revenue of $503,389 and a net loss of $12.3 million. A recent $50 million order from Lumilens could scale to $500 million over five years if production ramps up.
Nokia’s U.S. Broadband Order Arrives While AI-Driven Gains Test Supply Chain

Nokia’s U.S. Broadband Order Arrives While AI-Driven Gains Test Supply Chain

20 May 2026
Nokia shares rose 3.37% in Helsinki trading Wednesday after the FCC conditionally approved its Beacons and ONT devices, exempting them from U.S. Covered List restrictions. Nokia also transferred 975,289 treasury shares to equity plan participants. Dell’Oro Group forecasts the optical transport equipment market will grow 16% in 2026, driven by AI data centers.
Apellis Shares Disappear After Biogen’s $5.6 Billion Buy—One Play Left

Apellis Shares Disappear After Biogen’s $5.6 Billion Buy—One Play Left

20 May 2026
Biogen completed its acquisition of Apellis Pharmaceuticals, removing APLS shares from Nasdaq and paying investors $41 per share plus a contingent value right tied to Syfovre sales. Apellis shareholders tendered 82.4% of outstanding stock before the offer expired May 13. Biogen shares rose 0.9% to $192.34 Wednesday. The CVR could pay up to $4 if Syfovre meets future sales targets.
Cipla share price slides after USFDA flags Pharmathen: what the Form 483 says
Previous Story

Cipla share price slides after USFDA flags Pharmathen: what the Form 483 says

UnitedHealth stock falls despite new price targets as Wall Street eyes Jan. 27 earnings
Next Story

UnitedHealth stock falls despite new price targets as Wall Street eyes Jan. 27 earnings

Go toTop